Shark infested olive oil
Squalene and squalane are oils, often used in the production of cosmetics and vaccines. Originally derived from the liver oil of deepwater sharks, squalane is also available from olives, and since 2008 some important cosmetic firms have claimed to switch to this more ethical squalane supply. However, the shark oil offers a higher yield and lower costs, so suppliers face the temptation to disguise the oil?s origin, while continuing to exploit sharks. A method in Rapid Communications in Mass Spectrometry is reported to reveal the source, protecting sharks, as well as cosmetic firms and consumers.
Squalene and squalane are oils, often used in the production of cosmetics and vaccines. Originally derived from the liver oil of deepwater sharks, squalane is also available from olives, and since 2008 some important cosmetic firms have claimed to switch to this more ethical squalane supply. However, the shark oil offers a higher yield and lower costs, so suppliers face the temptation to disguise the oil’s origin, while continuing to exploit sharks. A method in Rapid Communications in Mass Spectrometry is reported to reveal the source,1 protecting sharks, as well as cosmetic firms and consumers.
The method uses an isotope ratio mass spectrometer coupled to an elemental analyser or gas chromatography/combustion system to measure the ratio of carbon-13 and carbon-12. The carbon-13/carbon-12 ratios were significantly lower in authentic olive oil than in shark samples, providing a method to distinguish between the two.
“Our method will protect both cosmetic firms and consumers from commercial fraud. It will also allow the origin of squalane within a finished product to be determined,” said Federica Camin, who works at the IASMA Research and Innovation Centre Fondazione Edmund Mach, in San Michele all’Adige, Italy and was one of the authors of the article. “Together, this will discourage the illegal fishing of deepwater sharks and thus contribute towards protecting sharks from the threat of extinction.”
1. F. Camin et al., Rapid. Commun. Mass Spectrom., on-line 19 May 2010.
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
